image description

Category: News

Lupus Research Alliance Announces Inaugural Recipients of Translational Bridge Award

The Lupus Research Alliance (LRA) is excited to announce the first-ever recipients of the Translational Bridge Award (TBA), established this year to accelerate the translation of groundbreaking research into potential treatments and diagnostics for lupus. The award aims to propel high-potential projects from LRA-funded foundational discoveries with strong commercialization potential or an opportunity for clinical […] Read More

Scientist Dedicates Her Research Career to Supporting Underrepresented Community

Two events coinciding at the exact same moment set the path for Dr. Vanessa Sue Wacleche to dedicate herself to lupus research. Just when she was choosing her specialty as a postdoctoral fellow, her great-uncle was diagnosed with lupus after months of debilitating symptoms. Also affirming this life-changing decision, Dr. Wacleche was motivated by her […] Read More

Lupus ABC Committee Tackling Patient Reported Outcomes at Upcoming Meeting

The Lupus Accelerating Breakthroughs Consortium (Lupus ABC), the public-private partnership which the LRA initiated with the U.S. Food and Drug Administration is working with many key lupus stakeholders on pursuing the most effective ways to accelerate lupus drug development. Read an interview with Dr. Patricia Katz who chairs the Lupus ABC Planning Committee on Patient […] Read More

Facing Lupus with a Positive Perspective

Radiating optimism despite living with lupus for most of her young life, this month’s Community Inspiration,17-year old Miah Andrade, has a powerful message to share during Hispanic Heritage Month: “Too many people don’t know what lupus is or that Hispanics are at greater risk for the disease than those in other groups. And even fewer […] Read More

Gazyva® Shows Positive Results in Phase 3 Lupus Nephritis Trial

The Lupus Research Alliance (LRA) and clinical research affiliate Lupus Therapeutics (LT) are excited to share positive news of the Phase 3 REGENCY clinical trial showing benefits of Gazyva® (obinutuzumab) in treating people with active lupus nephritis (inflammation of the kidney associated with lupus). In development as a potential treatment for lupus nephritis, Gazyva is approved in […] Read More

LRA Congratulates Dr. James Chen for Prestigious Lasker Award Recognizing Breakthrough Discovery of DNA Sensing Enzyme, cGAS  

The Lupus Research Alliance (LRA) proudly congratulates Dr. Zhijian “James” Chen on receiving the 2024 Albert Lasker Basic Medical Research Award for his revolutionary discovery of cGAS, a molecule that senses self and foreign DNA, activating the immune system. While cGAS is essential for detecting foreign DNA from pathogens like viruses and bacteria, in lupus, […] Read More